Press release - 21/03/2022 BMBF funds Heidelberg Junior Research Group for 3D Bioprinting Project Junior Professor Dr Daniela Duarte Campos has been awarded a substantial grant from the Federal Ministry of Education and Research (BMBF). She and her junior research group are investigating bioprinting for tissue and organ engineering at the Center for Molecular Biology of Heidelberg University and at the “3D Matter Made to Order” Cluster of Excellence, a collaboration between Ruperto Carola and Karlsruhe Institute of Technology (KIT).https://www.gesundheitsindustrie-bw.de/en/article/press-release/bmbf-funds-heidelberg-junior-research-group-3d-bioprinting-project
Article - 10/03/2021 Faster to single cells using miniature grinder Tissue cells are needed for medical diagnostics, cell therapies and tissue engineering, among other things. A novel tissue grinder gently and automatically dissociates cells from tissue. In November 2020, the newly founded biotech company Fast Forward Discoveries GmbH (FFX) delivered its first tissue grinders to customers.https://www.gesundheitsindustrie-bw.de/en/article/news/faster-single-cells-using-miniature-grinder
Press release - 28/01/2019 5,5 millions for project on smart matrices for knee cartilage repair A research project in cartilage regeneration, in which the Institute of Orthopaedic Research and Biomechanics at Ulm University participates together with partners from eight european countries, was recently financed by the European Commission with 5.5 million Euro. Named RESTORE, the project aims to create 3D matrices incorporating smart nanomaterials to repair knee cartilage lesions thereby reducing or delaying the onset of osteoarthritis,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/55-millions-for-project-on-smart-matrices-for-knee-cartilage-repair
Press release - 04/07/2018 Phase-I-trial approved for novel stem cell therapy for patients with ischemic cardiomyopathy Viscofan BioEngineering, the biomedical business unit of the world market leader for collagenous sausage casings Viscofan announced today that the Spanish Agency for Medicines (AEMPS) has given green light to carry out a clinical phase-I-trial with Viscofan BioEngineering’s first product for regenerative medicine. The novel therapy consisting of stem cells on a collagenous carrier membrane can now be tested on ten patients suffering from severe…https://www.gesundheitsindustrie-bw.de/en/article/press-release/phase-i-trial-approved-for-novel-stem-cell-therapy-for-patients-with-ischemic-cardiomyopathy
Article - 13/11/2017 An artificial heart valve with the potential to grow About 30,000 artificial heart valves are implanted in Germany every year. The durability of these heart valves presents a major challenge, requiring them to be exchanged time and again, especially in young patients. Researchers from the Stuttgart Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB have developed a new artificial heart valve material on which cells that are naturally present in a patient’s blood can form new…https://www.gesundheitsindustrie-bw.de/en/article/news/an-artificial-heart-valve-with-the-potential-to-grow
Article - 12/01/2017 Test system for skin damage caused by solar radiation Based on an accredited test method, the Fraunhofer IGB has developed an in vitro phototoxicity assay to measure the phototoxic potential of substances in medications and lotions used to protect the skin against environmental influences, which can become toxic when exposed to UV light. The assay uses human skin cells that have been grown into three-dimensional tissue as a human skin model. https://www.gesundheitsindustrie-bw.de/en/article/news/test-system-for-skin-damage-caused-by-solar-radiation
Article - 22/06/2015 3D bioprinting: replicating the shape of bone parts Prof. Dr. Günter Finkenzeller, head of the Research and Tissue Engineering Laboratory in the Department of Plastic and Hand Surgery at the Freiburg University Medical Centre, and Dr. Peter Koltay from the Department of Microsystems Engineering (IMTEK) at the University of Freiburg, are being given German Research Foundation (DFG) funds for a period of three years to develop a 3D printing technique for functional bone tissue containing blood…https://www.gesundheitsindustrie-bw.de/en/article/news/3d-bioprinting-replicating-the-shape-of-bone-parts
Article - 19/01/2015 Kay Gottschalk and the physics of cells You learn a great deal about the physical aspects of cells when you talk to Prof. Dr. Kay-E. Gottschalk. For example, their ability to react as solid and liquid, to adapt their environment to suit themselves and to exert and respond to forces. The 42-year-old has great respect for the smallest of living units, i.e. cells, which he calls smart composite materials. Working on the boundaries of medicine, biology, chemistry and physics, Gottschalk…https://www.gesundheitsindustrie-bw.de/en/article/news/kay-gottschalk-and-the-physics-of-cells
Article - 15/09/2014 Mesenchymal stromal cells: promising cell therapy candidates Mesenchymal stromal cells MSC are increasingly moving into the spotlight as the beacon of hope for somatic cell therapies. The biomedical research community is currently carrying out more than 300 clinical trials to investigate their suitability for a broad range of indications. Prof. Schrezenmeier professor of transfusion medicine and medical director at the Institute for Clinical Transfusion Medicine and Immunogenetics IKT in Ulm is involved in…https://www.gesundheitsindustrie-bw.de/en/article/news/mesenchymal-stromal-cells-promising-cell-therapy-candidates
Article - 03/03/2014 TETEC – the cartilage makers What you need is patient cells. The certified laboratories of TETEC AG use autologous cells to produce biological cartilage replacement for degenerated joints and intervertebral discs. The company considers itself the global market leader in the knee cartilage market. This means that the rapidly growing company is excellently placed for introducing new products to the regenerative medicine market.https://www.gesundheitsindustrie-bw.de/en/article/news/tetec-the-cartilage-makers
Article - 12/03/2013 Science to business – exit strategies for biotech companies The two directors of the consultancy firm LSCN Ltd. Dr. Alrik Koppenhöfer and Dr. Volker Ungermann explain the key issues involved in MA negotiations and licensing deals and how LSCN supports biotechnology companies and strategic investors in reaching their goals. Both managers agree that a good dose of realism is necessary. https://www.gesundheitsindustrie-bw.de/en/article/news/science-to-business-exit-strategies-for-biotech-companies
Article - 11/02/2013 REGiNA – the health region for regenerative medicine REGiNA is a users’ centre for regenerative medicine in the area bordered by the cities of Stuttgart and Tübingen and the Neckar-Alb region. It was established with the aim of translating a variety of advanced regenerative methods into broad clinical application. Providing a diverse and broad range of information, REGiNA is focused on making new treatment possibilities and the opportunities created by regenerative medicine known to doctors,…https://www.gesundheitsindustrie-bw.de/en/article/news/regina-the-health-region-for-regenerative-medicine
Dossier - 12/03/2012 Regenerative medicine makes use of patients’ own resources Regenerative medicine offers new therapeutic options for many diseases in which organ function or structure are damaged or lost. The majority of regenerative therapies involve cell-based methods that are often combined with innovative biomaterials. Regenerative therapies combine know-how from the biosciences with state-of-the-art medical technology and also benefit from progress in the engineering and material sciences.https://www.gesundheitsindustrie-bw.de/en/article/dossier/regenerative-medicine-makes-use-of-patients-own-resources
Press release - 09/02/2012 European tool enables companies to open up markets BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. This transnational EU project promotes innovations and cooperation in the biomaterials sector and is being funded for three years with a total of EUR 1.24 million. BioRegio STERN Management GmbH is committed to creating a successful pan-European cluster in regenerative medicine and tissue engineering. It is receiving EUR 223,000 during this period to develop a…https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-tool-enables-companies-to-open-up-markets
Press release - 30/09/2011 Blood Vessels from Your Printer Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
Article - 25/07/2011 Cell culturing as a taught subject: many more “Biberachs” are needed Cell culture technology is only taught at a handful of universities. However, this interdisciplinary subject is the core of the “Pharmaceutical Biotechnology” programme offered by the Biberach University of Applied Sciences. We talked about the subject with Professor Jürgen Hannemann, founding dean of the “Pharmaceutical Biotechnology” programme, and with Professor Friedemann Hesse, who runs the “cell culture technology” teaching programme.https://www.gesundheitsindustrie-bw.de/en/article/news/cell-culturing-as-a-taught-subject-many-more-biberachs-are-needed
Article - 30/04/2011 More efficient ways to erase cell memory Around five years ago for the first time ever regeneration biologists successfully turned back fully differentiated body tissue into pluripotent stem cells using a specific mixture of transcription factors. However the idea that it may one day become possible to create organ tissue is still a distant dream. The quantity of stem cells that can be obtained with current methods is still far too low. Dr. Maria Manukyan from the Centre for Biological…https://www.gesundheitsindustrie-bw.de/en/article/news/more-efficient-ways-to-erase-cell-memory
Article - 18/04/2011 Can tissue be glued together in a non-invasive way? At present, the use of substances to glue tissue together is only an idea, but it might eventually mean that surgeons will no longer need to use a needle and thread. The cellular and molecular biologist Rainer Wittig from the Ulm-based ILM hopes to develop such substances using a photochemical process. He is also planning to test substances that not only adhere to tissue but which will also be able to initiate the wound healing process.https://www.gesundheitsindustrie-bw.de/en/article/news/can-tissue-be-glued-together-in-a-non-invasive-way
Article - 10/04/2011 Wilhelm Aicher is committed to regenerative medicine research Laboratory-based regeneration of human cartilage and muscle tissue is his strong suit: Prof. Dr. Wilhelm K. Aicher brings his expertise in cellular and molecular biology to research focusing on the development of innovative therapies for the treatment of tissue damage. Successes such as a knee cartilage made from autologous (patients’ own) cells show that Aicher is on the right track.https://www.gesundheitsindustrie-bw.de/en/article/news/wilhelm-aicher-is-committed-to-regenerative-medicine-research
Press release - 03/04/2011 A vision of the future: whole-heart tissue engineering Scientists from the Department of Cardiac Surgery at the Heidelberg University Hospital have developed a bioreactor to produce a new heart from a patient’s own heart cells. The reactor mirrors the internal conditions of the human body. For example, the medium with the patient’s cells is pumped into the developing organ via small pulses that mirror the human heartbeat.https://www.gesundheitsindustrie-bw.de/en/article/press-release/a-vision-of-the-future-whole-heart-tissue-engineering
Press release - 19/10/2010 “Regenerative medicine has the potential to revolutionise medicine” More than 300 researchers from all over the world have gathered at the Haus der Wirtschaft in Stuttgart for the 4th Congress on Regenerative Biology and Medicine BioStar 2010. In this innovative field methods and therapies are developed whereby the bodys own regenerative processes are directly supported by cell biology tissue engineering and medical technology. https://www.gesundheitsindustrie-bw.de/en/article/press-release/regenerative-medicine-has-the-potential-to-revolutionise-medicine
Press release - 02/08/2010 NMI – 25 years of success The NMI in Reutlingen is one of the most prestigious research institutes in Germany, “a beacon of applied research” as the Minister of Economic Affairs recently called the institute. This success is no accident: for 25 years now, the institute with its interdisciplinary team has been working efficiently and actively towards this achievement. Moreover, it greatly succeeded in bridging science and industry.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmi-25-years-of-success
Press release - 26/07/2010 Tissue Engineering: Researcher from Ulm focussed on the regeneration of auricles “It is not that common, but nevertheless more frequent than assumed,” said Nicole Rotter, executive senior physician in the Department of Otorhinolaryngology, Head and Neck Surgery at Ulm University Hospital, referring to damaged or torn off auricles, the reconstruction of which is difficult and complex. Current methods involve the reconstruction of auricles from rib cartilage, which requires several steps, including the removal of three to four…https://www.gesundheitsindustrie-bw.de/en/article/press-release/tissue-engineering-researcher-from-ulm-focussed-on-the-regeneration-of-auricles
Press release - 25/06/2010 Von-Langenbeck Prize awarded for the first time to regenerative medicine methods In 2010 the Von-Langenbeck Prize was awarded to Dr. Thorsten Walles from the Schillerhöhe Hospital in Stuttgart. In cooperation with his partners Walles has developed an innovative method for regenerative medicine applications which involves the generation of tissue from the patients own cells to replace defective air pipes and oesophagus. The prize was awarded for the first time ever to a medical doctor in recognition of the development and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/von-langenbeck-prize-awarded-for-the-first-time-to-regenerative-medicine-methods
Article - 12/06/2010 Reliable evidence of efficacy using skin models and assays In the molecular biology laboratory at the Albstadt-Sigmaringen University of Applied Sciences a team led by Prof. Dr. Jörg Bergemann is developing and optimising assays that enable the quantitative determination of DNA damage and the investigation of repair mechanisms. The researchers exclusively use in vitro test systems. Using tissue engineering methods the researchers are developing a skin model for pharmacological efficacy and…https://www.gesundheitsindustrie-bw.de/en/article/news/reliable-evidence-of-efficacy-using-skin-models-and-assays